Amoroso, Vito
 Distribuzione geografica
Continente #
NA - Nord America 2.887
EU - Europa 1.445
AS - Asia 1.407
SA - Sud America 290
AF - Africa 24
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.062
Nazione #
US - Stati Uniti d'America 2.828
SG - Singapore 562
DE - Germania 416
CN - Cina 404
IT - Italia 268
BR - Brasile 249
UA - Ucraina 163
HK - Hong Kong 143
RU - Federazione Russa 132
FI - Finlandia 109
GB - Regno Unito 96
VN - Vietnam 95
PL - Polonia 76
TR - Turchia 60
IN - India 44
IE - Irlanda 39
CA - Canada 35
CZ - Repubblica Ceca 31
FR - Francia 25
SE - Svezia 22
BD - Bangladesh 20
AR - Argentina 17
ID - Indonesia 17
MX - Messico 15
NL - Olanda 14
BE - Belgio 13
ZA - Sudafrica 11
ES - Italia 10
JP - Giappone 10
EC - Ecuador 9
UZ - Uzbekistan 9
AT - Austria 6
CH - Svizzera 6
IQ - Iraq 6
PY - Paraguay 6
AU - Australia 5
LT - Lituania 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EE - Estonia 4
AM - Armenia 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
PA - Panama 3
RO - Romania 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
IR - Iran 2
LB - Libano 2
LV - Lettonia 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 6.062
Città #
Fairfield 357
Ashburn 274
Woodbridge 240
Singapore 233
Houston 158
Hong Kong 142
Seattle 136
Cambridge 134
Jacksonville 131
Chandler 123
Wilmington 114
Ann Arbor 110
Beijing 104
New York 92
Dallas 79
Warsaw 74
Munich 68
Princeton 65
Los Angeles 63
Helsinki 62
Istanbul 46
Dublin 39
Boardman 37
Dearborn 37
Turku 32
Redondo Beach 31
Ho Chi Minh City 28
Milan 28
Nanjing 28
Brescia 27
Chicago 25
Moscow 25
Shanghai 25
The Dalles 23
Brno 22
Changsha 20
Nürnberg 20
São Paulo 19
Nuremberg 18
London 17
Stockholm 17
Des Moines 16
Nanchang 16
Rome 16
San Francisco 16
Hanoi 14
Jakarta 14
Brooklyn 12
Brussels 12
Buffalo 12
Hebei 11
Montreal 11
Poplar 11
San Diego 11
Santa Clara 11
Shenyang 11
Dalmine 10
Jinan 10
Mexico City 10
Orem 10
Rio de Janeiro 10
Romola 10
Tokyo 10
Mumbai 9
Toronto 9
Atlanta 8
Belo Horizonte 8
Denver 8
Jiaxing 8
Olomouc 8
Tashkent 8
Tianjin 8
Boston 7
Chennai 7
Haiphong 7
Salt Lake City 7
San Mateo 7
Washington 7
Campinas 6
Guangzhou 6
Hangzhou 6
Johannesburg 6
Naples 6
Ningbo 6
Buenos Aires 5
Charlotte 5
Dietikon 5
Manchester 5
Orange 5
Perugia 5
Phoenix 5
Porto Alegre 5
Santo André 5
Venice 5
Verona 5
Zhengzhou 5
Amsterdam 4
Ankara 4
Augusta 4
Biên Hòa 4
Totale 3.815
Nome #
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 232
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 201
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 196
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 193
Regression of advanced neuroendocrine tumors among patients receiving placebo 176
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 173
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 171
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 169
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 163
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 162
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 160
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 160
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 160
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 158
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 156
Exemestane with ovarian suppression in premenopausal breast cancer. 156
Serum vitamin D and prostate cancer prognosis: The story continues 155
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 151
The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a Question Prompt Sheet versus Question Listing 146
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 143
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 142
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 138
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 135
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 123
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 121
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 120
Management of neuroendocrine tumors: State of the art 118
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 110
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 107
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 97
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 95
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data 92
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 90
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 82
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 81
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 79
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 79
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 78
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 75
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 75
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 74
Endocrine and Neuroendocrine Tumors: A Special Issue 73
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 73
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 64
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 63
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (carcinoid): Results from the Phase 2 ATLANT Study 62
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria 60
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 60
Adjuvant denosumab for early breast cancer-Evidence and controversy 58
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 51
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study 45
Regression of advanced neuroendocrine tumors among patients receiving placebo 44
Totale 6.145
Categoria #
all - tutte 29.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021357 0 0 0 0 0 46 36 60 49 69 69 28
2021/2022303 40 24 17 10 4 20 3 29 13 35 18 90
2022/2023364 39 10 9 22 35 87 3 31 59 13 36 20
2023/2024491 32 13 50 22 26 78 17 21 92 11 12 117
2024/20251.213 15 13 14 213 114 83 98 45 194 75 206 143
2025/20261.400 219 301 228 360 270 22 0 0 0 0 0 0
Totale 6.145